Sinovac Biotech Operating Expenses Growth & History (SVA)
Sinovac Biotech's operating expenses was $752.1M for fiscal 2025.
View full Sinovac Biotech company overviewSinovac Biotech annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $752.1M | $25.9M | +3.57% |
| 2024 | 2024-12-31 | $726.2M | −$311.1M | −29.99% |
| 2023 | 2023-12-31 | $1.04B | −$286.9M | −21.67% |
| 2022 | 2022-12-31 | $1.32B | $566.2M | +74.68% |
| 2021 | 2021-12-31 | $758.1M | $530.3M | +232.78% |
| 2020 | 2020-12-31 | $227.8M | $82.8M | +57.08% |
| 2019 | 2019-12-31 | $145.0M | −$14.6M | −9.14% |
| 2018 | 2018-12-31 | $159.6M | $50.9M | +46.85% |
| 2017 | 2017-12-31 | $108.7M | $59.2M | +119.42% |
| 2016 | 2016-12-31 | $49.5M | $4.2M | +9.32% |
| 2015 | 2015-12-31 | $45.3M | −$260,000 | −0.57% |
| 2014 | 2014-12-31 | $45.6M | $4.2M | +10.28% |
| 2013 | 2013-12-31 | $41.3M | −$9.9M | −19.40% |
| 2012 | 2012-12-31 | $51.3M | $18.9M | +58.53% |
| 2011 | 2011-12-31 | $32.3M | $2.3M | +7.66% |
| 2010 | 2010-12-31 | $30.0M | $8.1M | +36.63% |
| 2009 | 2009-12-31 | $22.0M | — | — |
Sinovac Biotech operating expenses trends
Over the last five fiscal years, Sinovac Biotech's operating expenses increased from $227.8M to $752.1M, a change of $524.3M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sinovac Biotech source filings ↗